Proposal to accelerate commercialization of bioscience research gathers steam as scope widens to include partners


Fate to be decided over the next year

Dr Fraser Mustard and a group of influential colleagues are preparing to tackle one the most vexing dilemmas facing Canadian health research. With the recent creation of the not-for-profit Canadian Biotechnology Commercialization Initiative (CBCI), its backers hope to avoid the so-called valley of death that has stalled or diluted the commercial potential of promising research as it moves from the lab bench to the marketplace.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.